157 related articles for article (PubMed ID: 34559307)
1. Defective NK cell expansion, cytotoxicity, and lack of ability to differentiate tumors from a pancreatic cancer patient in a long term follow-up: implication in the progression of cancer.
Kaur K; Ko MW; Chen F; Jewett A
Cancer Immunol Immunother; 2022 May; 71(5):1033-1047. PubMed ID: 34559307
[TBL] [Abstract][Full Text] [Related]
2. Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese Mice.
Kaur K; Chang HH; Topchyan P; Cook JM; Barkhordarian A; Eibl G; Jewett A
Front Immunol; 2018; 9():1229. PubMed ID: 29977235
[TBL] [Abstract][Full Text] [Related]
3. Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity.
Chovatiya N; Kaur K; Huerta-Yepez S; Chen PC; Neal A; DiBernardo G; Gumrukcu S; Memarzadeh S; Jewett A
Cancer Immunol Immunother; 2022 Dec; 71(12):2929-2941. PubMed ID: 35507102
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies.
Masuyama J; Murakami T; Iwamoto S; Fujita S
Cytotherapy; 2016 Jan; 18(1):80-90. PubMed ID: 26549384
[TBL] [Abstract][Full Text] [Related]
5. ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor.
Kaur K; Safaie T; Ko MW; Wang Y; Jewett A
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33440654
[TBL] [Abstract][Full Text] [Related]
6. NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis.
Jewett A; Kos J; Fong Y; Ko MW; Safaei T; Perišić Nanut M; Kaur K
Semin Cancer Biol; 2018 Dec; 53():178-188. PubMed ID: 30081230
[TBL] [Abstract][Full Text] [Related]
7. Progressive Impairment of NK Cell Cytotoxic Degranulation Is Associated With TGF-β1 Deregulation and Disease Progression in Pancreatic Cancer.
Jun E; Song AY; Choi JW; Lee HH; Kim MY; Ko DH; Kang HJ; Kim SW; Bryceson Y; Kim SC; Kim HS
Front Immunol; 2019; 10():1354. PubMed ID: 31281312
[TBL] [Abstract][Full Text] [Related]
8. Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction.
Peng YP; Zhang JJ; Liang WB; Tu M; Lu ZP; Wei JS; Jiang KR; Gao WT; Wu JL; Xu ZK; Miao Y; Zhu Y
BMC Cancer; 2014 Oct; 14():738. PubMed ID: 25274283
[TBL] [Abstract][Full Text] [Related]
9. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.
Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A
Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500
[TBL] [Abstract][Full Text] [Related]
10. Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients.
Kaur K; Cook J; Park SH; Topchyan P; Kozlowska A; Ohanian N; Fang C; Nishimura I; Jewett A
Front Immunol; 2017; 8():297. PubMed ID: 28424683
[TBL] [Abstract][Full Text] [Related]
11. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
Kozlowska AK; Kaur K; Topchyan P; Jewett A
Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.
Shenouda MM; Gillgrass A; Nham T; Hogg R; Lee AJ; Chew MV; Shafaei M; Aarts C; Lee DA; Hassell J; Bane A; Dhesy-Thind S; Ashkar AA
Breast Cancer Res; 2017 Jul; 19(1):76. PubMed ID: 28668076
[TBL] [Abstract][Full Text] [Related]
13. Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes.
Ko MW; Kaur K; Safaei T; Chen W; Sutanto C; Wong P; Jewett A
Cells; 2022 Feb; 11(4):. PubMed ID: 35203349
[TBL] [Abstract][Full Text] [Related]
14. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
[TBL] [Abstract][Full Text] [Related]
15. Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice.
Kaur K; Kozlowska AK; Topchyan P; Ko MW; Ohanian N; Chiang J; Cook J; Maung PO; Park SH; Cacalano N; Fang C; Jewett A
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31878338
[No Abstract] [Full Text] [Related]
16. Effect of surgery on pancreatic tumor-dependent lymphocyte asset: modulation of natural killer cell frequency and cytotoxic function.
Iannone F; Porzia A; Peruzzi G; Birarelli P; Milana B; Sacco L; Dinatale G; Peparini N; Prezioso G; Battella S; Caronna R; Morrone S; Palmieri G; Mainiero F; Chirletti P
Pancreas; 2015 Apr; 44(3):386-93. PubMed ID: 25621568
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Gingival NK Cells in Precancerous and Cancerous Stages of Pancreatic Cancer in KC and BLT-Humanized Mice.
Kaur K; Chang HH; Cook J; Eibl G; Jewett A
Front Immunol; 2017; 8():1606. PubMed ID: 29255459
[TBL] [Abstract][Full Text] [Related]
18. Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice.
Kaur K; Chen PC; Ko MW; Mei A; Senjor E; Malarkannan S; Kos J; Jewett A
Front Immunol; 2023; 14():1132807. PubMed ID: 37197660
[TBL] [Abstract][Full Text] [Related]
19. Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma.
Hosseinzadeh F; Ai J; Ebrahimi-Barough S; Seyhoun I; Hajifathali A; Muhammadnejad S; Hosseinzadeh F; Shadnoush M; Dabiri Oskouei F; Verdi J
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3797-3803. PubMed ID: 31870124
[TBL] [Abstract][Full Text] [Related]
20. In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.
Niu C; Jin H; Li M; Xu J; Xu D; Hu J; He H; Li W; Cui J
BMC Immunol; 2015 Oct; 16():61. PubMed ID: 26458364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
